The impact of oral semaglutide on glycemic control and weight reduction: a database analysis of dosing effects in Japanese individuals with type 2 diabetes.

Front Endocrinol (Lausanne) · 2025 · PMC12417148 · PMID 40933382

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

However, the proportion of individuals achieving HbA1c < 7.0% showed an increasing trend with continued use of 14 mg oral semaglutide.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.